Pirfenidone Capsules （400 mg）
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Beijing Continent Pharmaceutical Co, Ltd.
Overview
Pirfenidone Capsules （400 mg） is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Pirfenidone Capsules （400 mg） clinical trials
Explore related
Medical disclaimer. This page summarizes research about Pirfenidone Capsules （400 mg） for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.